2018 HHS指南:HIV感染的成人及青少年应用抗逆转录病毒药物治疗

2018-03-27 美国卫生和公共服务部 HHS官网

2018年3月,美国卫生和公共服务部(HHS)更新发布了HIV感染的成人及青少年应用抗逆转录病毒药物治疗指南,自抗逆转录病例药物出现以来,抗逆转录治疗HIV感染已经得到稳步提高,本文代表了刚逆转录治疗的最新知识,主要目的是针对HIV感染患者应用抗逆转录治疗提供指导。

中文标题:

2018 HHS指南:HIV感染的成人及青少年应用抗逆转录病毒药物治疗

英文标题:

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV (201803)

发布日期:

2018-03-27

简要介绍:

2018年3月,美国卫生和公共服务部(HHS)更新发布了HIV感染的成人及青少年应用抗逆转录病毒药物治疗指南,自抗逆转录病例药物出现以来,抗逆转录治疗HIV感染已经得到稳步提高,本文代表了刚逆转录治疗的最新知识,主要目的是针对HIV感染患者应用抗逆转录治疗提供指导。

 

拓展指南:HIV相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 HHS指南:HIV感染的成人及青少年应用抗逆转录病毒药物治疗)] GetToolGuiderByIdResponse(projectId=1, id=0f57d1c0015e77a1, title=2018 HHS指南:HIV感染的成人及青少年应用抗逆转录病毒药物治疗, enTitle=Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV (201803), guiderFrom=HHS官网, authorId=null, author=, summary=2018年3月,美国卫生和公共服务部(HHS)更新发布了HIV感染的成人及青少年应用抗逆转录病毒药物治疗指南,自抗逆转录病例药物出现以来,抗逆转录治疗HIV感染已经得到稳步提高,本文代表了刚逆转录治疗的最新知识,主要目的是针对HIV感染患者应用抗逆转录治疗提供指导。 , cover=, journalId=null, articlesId=null, associationId=545, associationName=美国卫生和公共服务部, associationIntro=美国卫生和公众服务部(United States Department of Health and Human Services;HHS)是维护美国公民健康,提供公众服务的联邦政府行政部门。 本部门于1979年10月17日由美国总统 吉米&middot;卡特签署的教育部组织法案(PL 96-88) 成立。该法案将原美国卫生教育和福利部(HEW)划分为包括G.I. Bill、退伍军人事务部的卫生及公共服务部和单独的教育部。这两个部门均于1980年5月4日开始运作。本部门由卫生和公众服务部长领导。 下属机构包括: CDC NIH CMS FDA HRSA SAMHSA 等。, copyright=0, guiderPublishedTime=Tue Mar 27 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年3月,美国卫生和公共服务部(HHS)更新发布了HIV感染的成人及青少年应用抗逆转录病毒药物治疗指南,自抗逆转录病例药物出现以来,抗逆转录治疗HIV感染已经得到稳步提高,本文代表了刚逆转录治疗的最新知识,主要目的是针对HIV感染患者应用抗逆转录治疗提供指导。 </P> <P> </P>拓展指南:<strong>与<font color=red>HIV</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=49bdb1c0015629b5" title="NCCN临床实践指南:HIV感染者癌症(2018.V1)" target=_blank>NCCN临床实践指南:HIV感染者癌症(2018.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=51cfd1c00152e513" title="2017 加拿大HIV暴露前预防和非职业性暴露后预防指南" target=_blank>2017 加拿大HIV暴露前预防和非职业性暴露后预防指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=962b01c0015085aa" title="2017 IDSA临床实践指南:HIV感染患者慢性疼痛的管理" target=_blank>2017 IDSA临床实践指南:HIV感染患者慢性疼痛的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ada3b1c001ae05e4" title="HIV合并结核分枝杆菌感染诊治专家共识" target=_blank>HIV合并结核分枝杆菌感染诊治专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=614c01c001a68333" title="HIV感染合并慢性肾脏病患者管理专家共识" target=_blank>HIV感染合并慢性肾脏病患者管理专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=HIV" target=_blank>有关HIV更多指南</a></ul>, tagList=[TagDto(tagId=3709, tagName=HIV感染), TagDto(tagId=8892, tagName=抗逆转录病毒药物)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5643, appHits=143, showAppHits=0, pcHits=4005, showPcHits=2079, likes=101, shares=4, comments=3, approvalStatus=1, publishedTime=Tue Apr 10 23:31:06 CST 2018, publishedTimeString=2018-03-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 10 23:31:06 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:38:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 HHS指南:HIV感染的成人及青少年应用抗逆转录病毒药物治疗)])
2018 HHS指南:HIV感染的成人及青少年应用抗逆转录病毒药物治疗
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=306023, encodeId=f320306023d2, content=学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Apr 15 12:30:53 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305068, encodeId=a4a0305068d0, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Thu Apr 12 09:02:59 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304607, encodeId=1ef830460ede, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 10 23:50:55 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
    2018-04-15 jihuaijun1112

    学习学习学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=306023, encodeId=f320306023d2, content=学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Apr 15 12:30:53 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305068, encodeId=a4a0305068d0, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Thu Apr 12 09:02:59 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304607, encodeId=1ef830460ede, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 10 23:50:55 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
    2018-04-12 龙胆草

    学习谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=306023, encodeId=f320306023d2, content=学习学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Sun Apr 15 12:30:53 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305068, encodeId=a4a0305068d0, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Thu Apr 12 09:02:59 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304607, encodeId=1ef830460ede, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Apr 10 23:50:55 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
    2018-04-10 清风拂面

    谢谢分享学习

    0